Peginterferon α-2b injection

DRUG7 trials

Sponsors

Zhangyu Bu, Xiamen Amoytop Biotech Co., Ltd., Zhenya Hong, Children's Hospital of Soochow University, West China Second University Hospital

Conditions

BronchiolitisChronic Hepatitis bCondylomata AcuminataEssential ThrombocythemiaHFMDPolycythemia VeraRespiratory Syncytial Virus (RSV)

Phase 2

Peginterferon α-2b Injection for Hydroxyurea Resistant or Intolerant ET

RecruitingNCT06552429

Xiamen Amoytop Biotech Co., Ltd.Essential Thrombocythemia

Start: 2024-08-29End: 2027-09-30Target: 27Updated: 2025-11-17

Unknown Phase

Peginterferon α-2b Combined CO2 Laser in Condylomata Acuminata

Not yet recruitingNCT06430190

Zhangyu BuCondylomata Acuminata

Start: 2024-07-31End: 2025-12-31Target: 30Updated: 2024-06-20

Efficacy and Safety of Peginterferon in ET and PV.

RecruitingNCT06734637

Zhenya HongEssential Thrombocythemia, Polycythemia Vera

Start: 2024-11-20End: 2027-11-20Target: 40Updated: 2024-12-16

Peginterferon α-2b Injection for the Treatment of Pediatric RSV Bronchiolitis

RecruitingNCT06827249

Children's Hospital of Soochow UniversityBronchiolitis

Start: 2025-03-31End: 2027-06-30Target: 90Updated: 2025-02-14

Peginterferon α-2b Injection for Aerosol Therapy in Pediatric Respiratory Syncytial Virus Pneumonia

RecruitingNCT06881056

West China Second University HospitalRespiratory Syncytial Virus (RSV)

Start: 2024-07-17End: 2026-03-31Target: 90Updated: 2025-03-18

Clinical Trial of Pegylated Interferon α-2b Via Nebulization for Treatment of Hand, Foot, and Mouth Disease .

RecruitingNCT07008755

Zhengzhou Children's Hospital, ChinaHFMD

Start: 2024-07-31End: 2027-12-31Target: 90Updated: 2025-06-06

Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.

RecruitingNCT07169656

The First Affiliated Hospital of Zhengzhou UniversityChronic Hepatitis b

Start: 2024-06-03End: 2032-12-31Target: 15000Updated: 2025-09-12